Reviva Pharmaceuticals Holdings, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-10.7M | $-10.7M | — | $106.7K |
| FY2022 | $-19.0M | $-19.0M | — | $176.7K |
| FY2023 | $-28.3M | $-28.3M | — | $3.4M |
| FY2024 | $-33.5M | $-33.5M | — | $1.6M |
| FY2025 | $-24.6M | $-24.6M | — | $2.2M |